Optex Systems Holdings, Inc. — Q1 FY2021 Form 10-Q Summary
Business Context and Reporting Period
Optex manufactures optical sighting systems, periscopes, rifle and surveillance sights, night-vision assemblies, and related optical products for the U.S. Department of Defense, foreign military customers, defense contractors, and commercial customers. Operations are conducted through the Richardson, Texas, and Applied Optics Center in Dallas, Texas, segments.
The filing covers the three months ended December 27, 2020, compared with the three months ended December 29, 2019. The statements are unaudited. The company had 98 full-time equivalent employees, and approximately 88% of revenue was domestic and 12% was generated from a Canadian customer.
Financial Performance and Position
| Metric | Q1 FY2021 | Q1 FY2020 | Change |
|---|---|---|---|
| Revenue | $4.471 million | $5.887 million | Down 24.1% |
| Gross profit | $835 thousand | $1.467 million | Down 43.1% |
| Gross margin | 18.7% | 24.9% | Down 6.2 percentage points |
| Operating income | $79 thousand | $718 thousand | Down $639 thousand |
| Net income | $1.087 million | $(679) thousand | Improved $1.766 million |
| Net income applicable to common shareholders | $726 thousand | $(679) thousand | Improved $1.405 million |
| Basic and diluted EPS | $0.09 | $(0.08) | Improved |
| Adjusted EBITDA | $199 thousand | $810 thousand | Down $611 thousand |
| Cash flow from operations | $423 thousand | $294 thousand | Improved $129 thousand |
The reported net income benefit was substantially driven by a $1.027 million noncash gain from the change in fair value of warrant liabilities, compared with a $1.251 million noncash loss in the prior-year quarter. Deemed dividends allocated to participating warrants reduced income applicable to common shareholders by $361 thousand.
At December 27, 2020, cash and cash equivalents were $4.627 million, accounts receivable were $2.138 million, and net inventory was $9.348 million. Working capital was approximately $12.5 million. Total assets were $19.850 million and total liabilities were $5.145 million.
The company used $81 thousand for capital expenditures and $415 thousand for stock repurchases during the quarter. Cash decreased by $73 thousand from September 27, 2020. The company had $377 thousand outstanding under its $2.25 million BBVA revolving credit facility, which matures April 15, 2022. Management stated that the company was compliant with its debt covenants.
Material Changes Versus the Prior Comparable Period
- Revenue declined $1.416 million, primarily due to lower demand and delayed customer orders. Richardson revenue decreased 16.9%, while Applied Optics Center revenue decreased 35.7%.
- Gross margin declined because of lower production volume, an unfavorable product mix, and the company’s substantial fixed manufacturing overhead.
- General and administrative expense was broadly stable at $756 thousand versus $749 thousand.
- Adjusted EBITDA fell to $199 thousand from $810 thousand, reflecting weaker core operating performance despite the reported GAAP net income.
- Backlog declined to $15.0 million from $16.3 million at September 27, 2020, an 8.0% decrease. Periscope backlog increased 11.3%, but sighting systems backlog decreased 34.5%.
- The company repurchased 208,592 shares for $415 thousand during the quarter. Cumulative repurchases totaled 314,325 shares for $615 thousand, leaving $385 thousand authorized under the $1 million program.
- Cash provided by operations increased despite lower profitability, primarily due to an $815 thousand reduction in accounts receivable, partly offset by a $557 thousand increase in inventory.
Guidance, Outlook, Risks, and Unusual Items
- Management anticipated a 25%–30% reduction in revenue volume during the first six months of FY2021 versus the first six months of FY2020. The filing does not provide a full-year revenue forecast.
- Management reported increased proposal activity and expected order growth over the following six to nine months, but stated that the timing and amount of new orders could not be determined.
- COVID-19-related delays in government contract awards, foreign military sales, inspections, testing, supply chains, and defense procurement processes remained the principal operating risk. Continued delays could reduce second-half revenue and profitability.
- The company implemented workforce and compensation reductions and was evaluating additional cost reductions over the next 60 to 90 days.
- Management stated that the company remained operational as essential defense infrastructure, with limited workforce disruption and generally timely customer collections and supplier payments.
- On January 11, 2021, the company announced a laser-protected periscope IDIQ contract with a base period of three years and two one-year options, with a maximum value of $14.4 million. The filing cautions that IDIQ contract values do not necessarily represent firm orders.
- On January 11, 2021, the company extended both facility leases. The amendments are expected to increase right-of-use assets by approximately $2.9 million and operating lease liabilities by approximately $3.0 million.
- The company’s 4.125 million outstanding warrants expire August 26, 2021 and are recorded as a Level 3 liability. Their fair value was $1.517 million at December 27, 2020, versus $2.544 million at September 27, 2020.
- Management stated that no material litigation was pending or threatened and that there were no material changes to previously disclosed risk factors.
Key Facts Investors Should Verify
- Whether customer orders, contract awards, and backlog recover as anticipated after COVID-19-related procurement delays.
- Whether revenue declines and fixed manufacturing costs continue to pressure gross margin and operating income.
- The quality and timing of the $15.0 million backlog, including the portion expected to convert to revenue during FY2021.
- The effect of the warrant expiration, exercises, and recurring fair-value remeasurement on reported earnings and potential dilution.
- Compliance with the BBVA facility’s fixed-charge coverage and other covenants as operating results change.
- The cash-flow impact of inventory requirements, stock repurchases, lease commitments, and the newly extended facility leases.
- Whether the announced IDIQ awards and increased proposal activity convert into funded purchase orders.